Claro Advisors’s Immunomedics Inc IMMU Stock Holding History

Claro Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,979	Closed	-$41K	–	1061
2018 Q4	$41K	Buy	+1,979	New	+$39.3K	0.03%	376

Other funds holding IMMU

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Claro Advisors's IMMU Position: Q1 2019 in Review

Claro Advisors sold out of Immunomedics Inc (IMMU) in Q1 2019, closing a stake of 1,979 shares — an estimated $41K sold.

Claro Advisors first reported a position in IMMU in Q4 2018 and held it in 1 quarter. The position peaked at $41K in Q4 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q1 2019.

Claro Advisors reported no remaining Immunomedics Inc position as of Q1 2019 after selling out during the quarter.
Claro Advisors sold 1,979 Immunomedics Inc shares in Q1 2019, an estimated $41K.
Claro Advisors first reported a position in Immunomedics Inc in Q4 2018 and held it in 1 quarter.
Claro Advisors's Immunomedics Inc position peaked at $41K in Q4 2018.
204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.